[1]ZHANG N,WU J,WANG Q,et al.Global burden of hematologic malignancies and evolution patterns over the past 30 years［J］.Blood Cancer Journal,2023,13(1):82.
[2]SWANSON PC.The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterifi- cation steps of V(D)J recombination［J］.Molecular Cell Biolchem,2001,21:449-458.
[3]SHIMAZAKIN,LIEBER MR.Histone methylation and V(D)J recombination［J］.International Journal of Hematology,2014,100(3):230-237.
[4]SCHATZ DG,OETTINGER MA,BALTIMORE D.The V(D)J recombination activating gene,RAG-1 ［J］.Cell,1989 ,59(6):1035-1048.
[5]DESIDERIO S.Temporal and spatial regulatory functions of the V(D)J recombinase［J］.Semin Immunol,2010,22:362-369.
[6]OETTINGER MA,SCHATZ DG,GORKA C,et al.RAG-1 and RAG-2,adjacent genes that synergistically activate V(D)J recombination［J］.Science,1990,248(4962):1517-1523.
[7]SCHATZ DG,SWANSON PC.V(D)J recombination:mechanisms of initiation［J］.Annual Review of Genetics,2011,45:167-202.
[8]QIU JX,KALE SB,YARNELL SCHULTZ H,et al.Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination［J］.Molecular Cell,2001,7(1):77-87.
[9]DIFILIPPANTONIO MJ,MCMAHAN CJ,EASTMAN QM,et al.RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination［J］.Cell,1996 87(2):253-262.
[10]KIRKHAM CM,BOYES J.Genome instability triggered by the V(D)J recombination by-product［J］.Molecular Cell Oncology,2019,6(4):1610323.
[11]KVPPERS R.Mechanisms of B-cell lymphoma pathogenesis［J］.Nat Rev Cancer,2005,5(4):251-262.
[12]ROMMEL PC,OLIVEIRA TY,NUSSENZWEIG MC,et al.RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaks［J］.Journal Of Experiment Medicine,2017,214(3):815-831.
[13]ALT FW,ZHANG Y,MENG FL,et al.Mechanisms of programmed DNA lesions and genomic instability in the immune system［J］.Cell,2013,152(3):417-429.
[14]KVPPERS R,DALLA-FAVERA R.Mechanisms of chromosomal translocations in B cell lymphomas［J］.Oncogene,2001,20(40):5580-5594.
[15] DELBRIDGE AR,PAN SH,VANDENBERG CJ,et al.RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice［J］.Journal of Experiment Medicine.2016,213(10):2039-2048.
[16]ZHANG Z,ZHAO L,WEI X,et al.Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML［J］.Oncology Letters,2018,16(4):5147-5159.
[17]OU R,HUANG J,SHEN H,et al.Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients［J］.Leukemia Research,2017,62:40-50.
[18]GOUGH SM,CHUNG YJ,APLAN PD.Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect［J］.PLoS One,2012,7(5):e36876.
[19]HUANG X,LIANG X,ZHU S,et al.Expression and clinical significance of RAG1 in myelodysplastic syndromes［J］.Hematology,2022,27(1):1122-1129.
[20]APPERLEY JF.Chronic myeloid leukaemia［J］.Lancet,2015,385(9976):1447-1459.
[21]ONIDA F,BALL G,KANTARJIAN HM,et al.Characteristics and outcome of patients with Philadelphia chromosome negative,bcr/abl negative chronic myelogenous leukemia［J］.Cancer,2002,95(8):1673-1684.
[22]于晓卓,李世常,赵小惠,等.RAG重组酶介导Ph+慢性粒细胞白血病细胞伊马替尼耐药的机制［C］//中国免疫学会.第十一届全国免疫学学术大会分会场交流报告集.安徽,2016:117-118.
YU XZ ,LI SC,ZHAO XH,et al.RAG recombinase mediates drug resistance in Ph+ chronic myeloid leukemia cells in imatinib［C］//Chinese Society of Immunology.The 11th National Conference on Immunology.Anhui,2016:117-118.
[23]KOSCHMIEDER S,VETRIE D.Epigenetic dysregulation in chronic myeloid leukaemia:A myriad of mechanisms and therapeutic options［J］.Seminars In Cancer Biology,2018,51:180-197.
[24]WAANDERS E,SCHEIJEN B,VAN DER MEER LT,et al.The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution［J］.PLoS Genetics,2012,8:e1002533.
[25]YUAN M,WANG Y,QIN M,et al.RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo［J］.Cancer Science,2021,112(7):2679-2691.
[26]ADNAN AWAD,DUFVA O,LANEVSKI A,et al.RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes,transcriptional profiles,and drug responses［J］.Leukemia,2021,35(4):1087-1099.
[27]THOMSON DW,SHAHRIN NH,WANG PPS,et al.Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia［J］.Leukemia,2020,34(8):2051-2063.
[28]AREF S,KHALED N,MENSHAWY NE,et al.Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia ［J］.Pediatric Hematology Oncology,2020,37(5):380-389.
[29]CHEN D,CAMPONESCHI A,NORDLUND J,et al.RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children［J］.Cancer Medicine,2021,10(12):3997-4003.
[30]HAN Q,MA J,GU Y,et al.RAG1 high expression associated with IKZF1 dysfunction in adult B-cell acute lymphoblastic leukemia［J］.Journal Cancer,2019,10(16):3842-3850.
[31]BHOJWANI D,PEI D,SANDLUND JT,et al.ETV6-RUNX1-positive childhood acute lymphoblastic leukemia:improved outcome with contemporary therapy［J］.Leukemia,2012,26(2):265-270.
[32]PAPAEMMANUIL E,RAPADO I,LIY,et al.RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia［J］.Nature Genetics,2014,46(2):116-125.
[33]KIRKHAM CM,SCOTT JNF,WANG X,et al.Cut-and-Run:A distinct mechanism by which V(D)J recombination causes genome instability［J］.Molecular Cell,2019,74(3):584-597.
[34]GREAVES M.A causal mechanism for childhood acute lymphoblastic leukaemia［J］.Nature Reviews Cancer,2018,18(8):471-484.
[35]HVBNER S,CAZZANIGA G,FLOHR T,et al.High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias［J］.Leukemia,2003,18:84-91.
[36]WAANDERS E,SCHEIJEN B,VAN DERT MEER LT,et al.The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution［J］.PLoS Genetics,2012,8:e1002533.
[37]ZHANG M,SWANSON PC.V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies［J］.Journal Biological Chemistry,2008,283:6717-6727.
[38]ROSS ME,ZHOU X,SONG G,et al.Classification of pediatric acute lymphoblastic leukemia by gene expression profiling［J］.Blood,2003,102:2951-2959.
[39]SWAMINATHAN S,KLEMML L,PARK E,et al.Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia［J］.Nature Immunology,2015,16:766-774.
[40]RODRIGUEZ-HERNANDEZ G,HAUER J,MARTIN-LORENZO A,et al.Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases［J］.Cancer Research,2017,77(16):4365-4377.
[41]JAKOBCZYK H,JIANG Y,DEBAIZE L,et al.ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression:one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis［J］.Leukemia,2022,36(2):549-554.
[42]姜艳.ETV6-RUNX1和RUNX1直接调控RAG1表达的机制研究［D］.长春：吉林大学,2022.
JANG Y.The mechanism by which ETV6-RUNX1and Runx1 directly regulate RAG1 expression was investigated［D］.Changchun:Jilin University,2022.
[43]KUO TC,SCHLISSEL MS.Mechanisms controlling expression of the RAG locus during lymphocyte development［J］.Current Opinion Immunology,2009,21(2):173-178.
[44]SILL H,GOLDMAN JM,CROSS NC.Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia［J］.Blood,1995,85(8):2013-2016.
[45]KUMARI R,ROY U,DESAI S,et al.MicroRNA miR-29c regulates RAG1 expression and modulates V(D)J recombination during B cell development［J］.Cell Repoters,2021,36(2):109390.
[46]BAILEY MH,TOKHEIM C,PORTA-PARDO E,et al.Comprehensive characterization of cancer driver genes and mutations［J］.Cell,2018,173(2):371-385.
[47]MAEHAMA T.PTEN:its deregulation and tumorigenesis［J］.Biological Pharmaceutical Bulletin,2007,30(9):1624-1627.
[48]WU Y,ZHU H,WU H.PTEN in regulating hematopoiesis and leukemogenesis［J］.Cold Spring Harbor Perspectives Medicine,2020,10(10):a036244.
[49]PALOMERO T,SULIS ML,CORTINA M,et al.Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia［J］.Nature Medicine,2007,13(10):1203-1210.
[50]MENDES RD,SARMENTO LM,CANTE-BARRETT,et al.PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events ［J］.Blood,2014,124(4):567-578.
[51]DONG Y,GUO H,WANG D,et al.Genome-wide analysis identifies Rag1 and Rag2 as novel Notch1 transcriptional targets in thymocytes［J］.Frontiers In Cell and Development Biology,2021,9:703338.
[52]KOURTI N,LAZARIS C,HOCKEMEYER K,et al.Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia［J］.Nature Medicine,2018,24(8):1157-1166.
[53]RIZ I,HAWLEY TS,LUU TV,et al.TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells［J］.Molecular Cancer,2010,9:181.
[54]HERMAN JG,BAYLIN SB.Gene silencing in cancer in association with promoter hypermethylation［J］.New England Journal of Medicine,2003,349:2042-2054.
[55]NAMBIAR M,GOLDSMITH G,MOORTHY BT,et al.Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma［J］.Nucleic Acids Research,2011,39(3):936-948.
[56]TSAI AG,LU H,RAGHAVAN SC,et al.Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity［J］.Cell,2008,135(6):1130-1142.
[57]MAHOWALD GK,BARON JM,SLECKMAN BP.Collateral damage from antigen receptor gene diversification［J］.Cell,2008,135:1009-1012.
[58]GOSTISSA M,ALT FW,CHIARLE R.Mechanisms that promote and suppress chromosomal translocations in lymphocytes［J］.Annual Review Immunology,2011,29:319-350.
[59]NUSSENZWEIG A,NUSSENZWEIG MC.Origin of chromosomal translocations in lymphoid cancer［J］.Cell,2010,141:27-38.
[60]ZHANG L,REYNOLDS TL,SHAN XC,et al.Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis［J］.Immunity,2011,34(2):163-174.
[61]TSIMBOURI P,DROTAR ME,COY JL,et al.bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes［J］.Oncogene,2002,21(33):5182-5187.
[62]PARANJAPE AM,DESAI SS,NISHANA M,et al .Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers［J］.PLoS Genetics,2022,18(10):e1010421.
[63]BENHAMOU D,LABI V,GETAHUN A,et al.The c-Myc/miR17-92/PTEN axis tunes PI3K activity to control expression of recombination activating genes in early B cell development［J］.Frontiers In Immunology,2018,9:2715.
[64]FENG M,YANG K,WANG J,et al.First report of FARSA in the regulation of cell cycle and survival in mantle cell lymphoma cells via PI3K-AKT and FOXO1-RAG1 axes［J］.International Journal of Molecular Sciences,2023,24(2):1608.
[65]YUAN L,SUN L,YANG S,et al.B7-H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma［J］.Annals of Translational Medicine,2021,9(4):328.
[66]BIANCHI JJ,MURIGNEUX V,BEDORA-FAURE M,et al.Breakage-fusion-bridge events trigger complex genome rearrangements and amplifications in developmentally arrested T cell lymphomas［J］.Cell Reports,2019,27(10):2847-2858.